Molecular Landscape with Human Liver Cancer Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B 6 C 3 F 1 Mice : Similarities in the

Hepatocellular carcinoma (HCC) is an important cause of morbidity and mortality worldwide. Although the risk factors of human HCC are well known, the molecular pathogenesis of this disease is complex, and in general, treatment options remain poor. The use of rodent models to study human cancer has been extensively pursued, both through genetically engineered rodents and rodent models used in carcinogenicity and toxicology studies. In particular, the B6C3F1 mouse used in the National Toxicology Program (NTP) two-year bioassay has been used to evaluate the carcinogenic effects of environmental and occupational chemicals, and other compounds. The high incidence of spontaneous HCC in the B6C3F1 mouse has challenged its use as a model for chemically induced HCC in terms of relevance to the human disease. Using global gene expression profiling, we identify the dysregulation of several mediators similarly altered in human HCC, including re-expression of fetal oncogenes, upregulation of protooncogenes, downregulation of tumor suppressor genes, and abnormal expression of cell cycle mediators, growth factors, apoptosis regulators, and angiogenesis and extracellular matrix remodeling factors. Although major differences in etiology and pathogenesis remain between human and mouse HCC, there are important similarities in global gene expression and molecular pathways dysregulated in mouse and human HCC. These data provide further support for the use of this model in hazard identification of compounds with potential human carcinogenicity risk, and may help in better understanding the mechanisms of tumorigenesis resulting from chemical exposure in the NTP two-year carcinogenicity bioassay.

[1]  K. Tomer,et al.  Gene Expression and Mutation Assessment Provide Clues of Genetic and Epigenetic Mechanisms in Liver Tumors of Oxazepam-Exposed Mice , 2011, Veterinary pathology.

[2]  M. Ronaghi,et al.  Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.

[3]  Wenge Guo,et al.  Controlling False Discoveries in Multidimensional Directional Decisions, with Applications to Gene Expression Data on Ordered Categories , 2010, Biometrics.

[4]  G. Cabibbo,et al.  Epidemiology, risk factors and surveillance of hepatocellular carcinoma. , 2010, European review for medical and pharmacological sciences.

[5]  H. Papadaki,et al.  Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. , 2010, Histology and histopathology.

[6]  Donald Wlodkowic,et al.  Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy. , 2009, European journal of pharmacology.

[7]  F. Heindryckx,et al.  Experimental mouse models for hepatocellular carcinoma research , 2009, International journal of experimental pathology.

[8]  Jan-Gowth Chang,et al.  Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications , 2009, Journal of Cancer Research and Clinical Oncology.

[9]  Goberdhan P Dimri,et al.  BMI1 Cooperates with H-RAS to Induce an Aggressive Breast Cancer Phenotype with Brain Metastases , 2009, Oncogene.

[10]  R. Floyd,et al.  In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model. , 2009, Journal of lipid research.

[11]  S. Thorgeirsson,et al.  Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. , 2009, Cancer research.

[12]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Maronpot Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains , 2009, Journal of toxicologic pathology.

[14]  K. Cooper,et al.  Glypican-3: A Novel Diagnostic Marker for Hepatocellular Carcinoma and More , 2009, Advances in anatomic pathology.

[15]  T. Mok,et al.  New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Shu-Hui Zhang,et al.  Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. , 2008, Human pathology.

[17]  V. Herlea,et al.  Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[18]  L. Michel,et al.  c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. , 2008, World journal of gastroenterology.

[19]  Jorng-Tzong Horng,et al.  Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma , 2008, Oncogene.

[20]  S. Thibodeau,et al.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. , 2008, Journal of hepatology.

[21]  A. Jacobsson,et al.  Steroid hormones control circadian ELOVL3 expression in mouse liver , 2008 .

[22]  Hongmin Li,et al.  A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers , 2008, PLoS Genetics.

[23]  S. Thorgeirsson,et al.  Transforming growth factor‐β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer , 2008, Hepatology.

[24]  Y. Takeda,et al.  Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. , 2008, European journal of cancer.

[25]  I. Tischoff,et al.  DNA methylation in hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[26]  Y. Matsuda Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[27]  A. Buchmann,et al.  Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. , 2008, Mutation research.

[28]  R. Fry,et al.  Hepatocellular carcinoma associated with liver-gender disruption in male mice. , 2007, Cancer research.

[29]  Ji-Shin Lee,et al.  Genetic alterations of Wnt signaling pathway–associated genes in hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.

[30]  Sheng-Nan Lu,et al.  Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. , 2007, Oncology reports.

[31]  C. Fan,et al.  The Role of Gas1 in Embryonic Development and its Implications for Human Disease , 2007, Cell cycle.

[32]  Goberdhan P Dimri,et al.  Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. , 2007, Cancer research.

[33]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[34]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[35]  J. Yun,et al.  Identification and characterization of BH3 domain protein Bim and its isoforms in human hepatocellular carcinomas , 2007, Apoptosis.

[36]  Yong Zhang,et al.  Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[37]  O. Mariani,et al.  JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. , 2007, Cancer cell.

[38]  C. Harris,et al.  TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer , 2007, Oncogene.

[39]  V. Mazzaferro,et al.  Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.

[40]  Stéphane Larochelle,et al.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. , 2007, Molecular cell.

[41]  S. Cheung,et al.  Atypical localization of membrane type 1‐matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma , 2007, Molecular carcinogenesis.

[42]  Jie-quan Yang,et al.  Elevated Expression of Autocrine Motility Factor Receptor Correlates with Overexpression of RhoC and Indicates Poor Prognosis in Hepatocellular Carcinoma , 2007, Digestive Diseases and Sciences.

[43]  K. Arai,et al.  Phosphorylation of MCM4 by Cdc7 Kinase Facilitates Its Interaction with Cdc45 on the Chromatin*♦ , 2006, Journal of Biological Chemistry.

[44]  V. Paradis,et al.  Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. , 2006, Human pathology.

[45]  M. Schwarz,et al.  Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis. , 2006, Toxicology.

[46]  G. Sumara,et al.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. , 2006, Genes & development.

[47]  P. Pineau,et al.  Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma , 2006, Molecular and Cellular Endocrinology.

[48]  V. Radha,et al.  Involvement of caspase 1 and its activator Ipaf upstream of mitochondrial events in apoptosis , 2006, The FEBS journal.

[49]  Xiaohong Wu,et al.  Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[50]  Fumio Hanaoka,et al.  Site‐specific phosphorylation of MCM4 during the cell cycle in mammalian cells , 2006, The FEBS journal.

[51]  Q. Hong,et al.  WOX1 Is Essential for Tumor Necrosis Factor-, UV Light-, Staurosporine-, and p53-mediated Cell Death, and Its Tyrosine 33-phosphorylated Form Binds and Stabilizes Serine 46-phosphorylated p53* , 2005, Journal of Biological Chemistry.

[52]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Miyazaki,et al.  Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Lobe,et al.  Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. , 2005, Cancer research.

[55]  Hiroki Nagase,et al.  Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma , 2005, International journal of gastrointestinal cancer.

[56]  B. Rozell,et al.  Human sterol 12α-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern , 2005, Histochemistry and Cell Biology.

[57]  J. Squire,et al.  Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells , 2005, Laboratory Investigation.

[58]  M. Makuuchi,et al.  Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. , 2005, International journal of oncology.

[59]  O. Musso,et al.  Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma , 2005, FEBS letters.

[60]  S. Thorgeirsson,et al.  Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse Models of Liver Cancer , 2005, Toxicologic pathology.

[61]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[62]  Joo Heon Kim,et al.  Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. , 2004, Breast.

[63]  J. Fox,et al.  Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice , 2004, Toxicologic pathology.

[64]  J. Thacker,et al.  The XRCC genes: expanding roles in DNA double-strand break repair. , 2004, DNA repair.

[65]  J. Ludes-Meyers,et al.  Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma , 2004, British Journal of Cancer.

[66]  T. Kudo,et al.  Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death , 2004, The Journal of cell biology.

[67]  Philip M. Long,et al.  Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach , 2004, Hepatology.

[68]  B. Mellström,et al.  Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo , 2004, Neurobiology of Disease.

[69]  M. Lohuizen,et al.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas , 2004, Nature.

[70]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[71]  Mengsen Li,et al.  Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. , 2004, World journal of gastroenterology.

[72]  Chiao-Ying Lin,et al.  Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[73]  R. Xu,et al.  An update on the molecular genetics of hepatocellular carcinoma. , 2004, Seminars in liver disease.

[74]  H. Zhang,et al.  Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[75]  S. Hirohashi,et al.  Possible involvement of tetraspanin CO‐029 in hematogenous intrahepatic metastasis of liver cancer cells , 2003, Journal of gastroenterology and hepatology.

[76]  Wei Wang,et al.  Expression and significance of RhoC gene in hepatocellular carcinoma. , 2003, World journal of gastroenterology.

[77]  D. Tenen,et al.  Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPα DNA binding via leucine zipper domain interaction , 2003, Oncogene.

[78]  T. Devereux,et al.  Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. , 2003, Toxicology and applied pharmacology.

[79]  Wen Shi,et al.  Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. , 2003, Gastroenterology.

[80]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[81]  Stephen C. West,et al.  Molecular views of recombination proteins and their control , 2003, Nature Reviews Molecular Cell Biology.

[82]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[83]  E. Wagner,et al.  Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.

[84]  Jian-hua Xu,et al.  Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[85]  Wei-Min Liu,et al.  Robust estimators for expression analysis , 2002, Bioinform..

[86]  Judith Campisi,et al.  The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. , 2002, Cancer research.

[87]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[88]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[89]  Tatjana Crnogorac-Jurcevic,et al.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.

[90]  E. Wagner,et al.  Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c‐jun in the liver , 2002, The EMBO journal.

[91]  D. Zimonjic,et al.  Chromosome‐mediated alterations of the MYC gene in human cancer , 2002, Journal of cellular and molecular medicine.

[92]  Y. Morishita,et al.  Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. . , 2002, Anticancer research.

[93]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[94]  S. Hirohashi,et al.  Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. , 2001, Journal of hepatology.

[95]  S. Thibodeau,et al.  hMLH1 and hMSH2 expression in human hepatocellular carcinoma. , 2001, International journal of oncology.

[96]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[97]  M. Lohuizen,et al.  The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression , 2001, British Journal of Cancer.

[98]  Y. Tan,et al.  Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. , 2001, World journal of gastroenterology.

[99]  S. Rane,et al.  Janus kinases: components of multiple signaling pathways , 2000, Oncogene.

[100]  M. Buendia Genetics of hepatocellular carcinoma. , 2000, Seminars in cancer biology.

[101]  D. Graham,et al.  Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. , 2000, The American journal of pathology.

[102]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[103]  B. le Bail,et al.  Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma , 1999, The Journal of pathology.

[104]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[105]  R. Poulsom,et al.  Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors. , 1998, The American journal of surgical pathology.

[106]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[107]  W. Bodmer,et al.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[108]  A. Evdokiou,et al.  Tumor‐suppressive activity of the growth arrest‐specific gene GAS1 in human tumor cell lines , 1998, International journal of cancer.

[109]  A. Hochberg,et al.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.

[110]  S. Hirohashi,et al.  E‐cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma , 1996, Hepatology.

[111]  J. Ward,et al.  Emerging Issues in Mouse Liver Carcinogenesis , 1996, Toxicologic pathology.

[112]  V. Castronovo,et al.  Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. , 1995, Oncogene.

[113]  J. Roth,et al.  Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. , 1995, Oncogene.

[114]  R. Maronpot,et al.  Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. , 1995, Toxicology.

[115]  R. Levine,et al.  Carbonic Anhydrase III. OXIDATIVE MODIFICATION IN VIVO AND LOSS OF PHOSPHATASE ACTIVITY DURING AGING (*) , 1995, The Journal of Biological Chemistry.

[116]  J M Ward,et al.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. , 1994, Journal of the National Cancer Institute.

[117]  S. Hirohashi,et al.  Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. , 1994, Cancer research.

[118]  V. Castronovo,et al.  The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. , 1994, Biochemical pharmacology.

[119]  Y. Haupt,et al.  bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. , 1993, Oncogene.

[120]  H. Hsu,et al.  Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. , 1993, Journal of the Formosan Medical Association = Taiwan yi zhi.

[121]  A. Nonomura,et al.  Alpha‐fetoprotein production by hepatocellular carcinoma is prognostic of poor patients survival , 1992, Journal of surgical oncology.

[122]  W. Alexander,et al.  Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice , 1991, Cell.

[123]  E. Farber Pathogenesis of liver cancer. , 1974, Archives of pathology.

[124]  M. Zöller Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.

[125]  Jing Zhao,et al.  Wnt/beta-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells. , 2009, Cell cycle.

[126]  谷口 哲郎 Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 , 2008 .

[127]  H. Huber,et al.  PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. , 2007, Oncogene.

[128]  J. Abecassis,et al.  Cisplatin-induced genes as potential markers for thyroid cancer , 2004, Cellular and Molecular Life Sciences CMLS.

[129]  M. Yuen,et al.  Expression of c‐Myc, c‐Fos, and c‐Jun in hepatocellular carcinoma , 2001, Cancer.

[130]  R. Ge,et al.  Effect of trichloroethylene on DNA methylation and expression of early‐intermediate protooncogenes in the liver of B6C3F1 mice , 1999, Journal of biochemical and molecular toxicology.

[131]  F. May,et al.  Trefoil proteins: their role in normal and malignant cells. , 1997, The Journal of pathology.

[132]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[133]  S. Thorgeirsson,et al.  Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. , 1993, Cancer research.